Point72 Hong Kong’s NextCure NXTC Stock Holding History

Point72 Hong Kong’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1	Closed	–	–	2237
2021 Q3	$0	Hold	1	–	–	﹤0.01%	2309
2021 Q2	$0	Buy	+1	New	+$102	﹤0.01%	2229
2020 Q3	–	Sell	-4	Closed	-$1K	–	1417
2020 Q2	$1K	Buy	+4	New	+$1.52K	﹤0.01%	1096

Other funds holding NXTC

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

LOAMS

Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Point72 Hong Kong's NXTC Position: Q4 2021 in Review

Point72 Hong Kong sold out of NextCure (NXTC) in Q4 2021, closing a stake of 1 share.

Point72 Hong Kong first reported a position in NXTC in Q2 2020 and held it in 3 quarters. The position peaked at $1K in Q2 2020. 71 funds tracked by Wall St. Rank hold NXTC as of Q4 2021.

Point72 Hong Kong reported no remaining NextCure position as of Q4 2021 after selling out during the quarter.
Point72 Hong Kong sold 1 NextCure share in Q4 2021.
Point72 Hong Kong first reported a position in NextCure in Q2 2020 and held it in 3 quarters.
Point72 Hong Kong's NextCure position peaked at $1K in Q2 2020.
71 funds tracked by Wall St. Rank held NextCure as of Q4 2021.

Based on Point72 Hong Kong's 13F filing for Q4 2021, filed 14 Feb 2022.